During the webinar, we will first discuss the currently available methods used to detect hypoxia using both MRI and PET imaging and in particular, the [64Cu]-CuATSM metabolism and the use of this radiopharmaceutical in different preclinical and clinical pathologic models. We will provide examples of hypoxia imaging in brain tumor situations (high grade gliomas, brain metastases) in rodents and in the clinic.
Speakers:
1. Dr Samuel Valable, Research Director, ISTCT Lab at Cyceron Research Center
2. Dr. Mickaël Bourgeois, Radiopharmacist –Associate Professor, Nantes University Hospital – Nuclear Medicine Department, ARRONAX Cyclotron – Radiopharmacy Unit
Please access registration link